Dermatol. praxi. 2021;15(2):94-96 | DOI: 10.36290/der.2021.018
Biological treatment of severe atopic dermatitis in an adolescent patient
- Ústav imunologie - dětská ambulance, 2. LF UK a FN Motol, Praha
We are presenting a case report of a boy with severe atopic dermatitis refractory to systemic immunosupresive treatment with growth retardation, secondary hypocorticalism after repeated systemic corticotherapy. Treatment with monoclonal antibody inhibiting alpha subunit of interleukin 4 receptor (IL-4Rα) dupilumab was successfull.
Keywords: atopic dermatitis, systemic immunosuppresive therapy, dupilumab, type 2 inflammation.
Published: September 2, 2021 Show citation
References
- Weidinger S, Novak N. Atopic Dermatitis. Lancet 2016: 387 (1023): 1109-1122.
Go to original source... 
Go to PubMed... - Wollenberg A, Barbarot S, Bieber T, Christen-Zaech S, Deleuran M, Fink-Wagner A, Gieler U, Girolomoni G, Lau S, Muraro A, Czarnecka-Operacz M, Schäfer T, Schmid-Grendelmeier P, Simon D, Szalai Z, Szepietowski JC, Taïeb A, Torrelo A, Werfel T, Ring J; European Dermatology Forum (EDF), the European Academy of Dermatology and Venereology (EADV), the European Academy of Allergy and Clinical Immunology (EAACI), the European Task Force on Atopic Dermatitis (ETFAD), European Federation of Allergy and Airways Diseases Patients' Associations (EFA), the European Society for Dermatology and Psychiatry (ESDaP), the European Society of Pediatric Dermatology (ESPD), Global Allergy and Asthma European Network (GA2LEN) and the European Union of Medical Specialists (UEMS). Consensus-based European guidelines for treatment of atopic eczema (atopic dermatitis) in adults and children: part I. J Eur Acad Dermatol Venereol. 2018; 32(5): 657-682. Erratum in: J Eur Acad Dermatol Venereol. 2019; 33(7): 1436. Go to original source... Go to PubMed...
- Wollenberg A, Barbarot S, Bieber T, Christen-Zaech S, Deleuran M, Fink-Wagner A, Gieler U, Girolomoni G, Lau S, Muraro A, Czarnecka-Operacz M, Schäfer T, Schmid-Grendelmeier P, Simon D, Szalai Z, Szepietowski JC, Taïeb A, Torrelo A, Werfel T, Ring J; European Dermatology Forum (EDF), the European Academy of Dermatology and Venereology (EADV), the European Academy of Allergy and Clinical Immunology (EAACI), the European Task Force on Atopic Dermatitis (ETFAD), European Federation of Allergy and Airways Diseases Patients' Associations (EFA), the European Society for Dermatology and Psychiatry (ESDaP), the European Society of Pediatric Dermatology (ESPD), Global Allergy and Asthma European Network (GA2LEN) and the European Union of Medical Specialists (UEMS). Consensus-based European guidelines for treatment of atopic eczema (atopic dermatitis) in adults and children: part II. J Eur Acad Dermatol Venereol. 2018; 32(6): 850-878. Go to original source... Go to PubMed...
- Souhrn údajů o přípravku: Dupixent 2021 dostupné na https://www.ema.europa.eu/en/documents/product-information/dupixent-epar-product-information_en.pdf.
- Agache I, Akdis CA, Akdis M, Brockow K, Chivato T, del Giacco S, Eiwegger T, Eyerich K, Giménez-Arnau A, Gutermuth J, Guttman-Yassky E, Maurer M, Ogg G, Ong PY, O'Mahony L, Schwarze J, Warner A, Werfel T, Palomares O, Jutel M. EAACI Biologicals Guidelines - dupilumab for children and adults with moderate-to-severe atopic dermatitis. Allergy 2021; 76: 988-1009. Go to original source... Go to PubMed...
- Avioli LV. Glucocorticoid Effects on Statural Growth, Rheumatology 1993: 32(suppl 2): 27-30. Go to original source... Go to PubMed...
- Wang FP, Tang XJ, Wei CQ, Xu LR, Mao H, Luo FM. Dupilumab treatment in moderate-to-severe atopic dermatitis: A systematic review and meta-analysis. J Dermatol Sci. 2018; 90(2): 190-198. Go to original source... Go to PubMed...
- Paller AS, Siegfried EC, Thaçi D, Wollenberg A, Cork MJ, Arkwright PD, Gooderham M, Beck LA, Boguniewicz M, Sher L, Weisman J, O'Malley JT, Patel N, Hardin M, Graham NMH, Ruddy M, Sun X, Davis JD, Kamal MA, Khokhar FA, Weinreich DM, Yancopoulos GD, Beazley B, Bansal A, Shumel B. Efficacy and safety of dupilumab with concomitant topical corticosteroids in children 6 to 11 years old with severe atopic dermatitis: A randomized, double-blinded, placebo-controlled phase 3 trial. J Am Acad Dermatol. 2020; 83(5): 1282-1293. Go to original source... Go to PubMed...
- Seegräber M, Srour J, Walter A, Knop M, Wollenberg A. Dupilumab for treatment of atopic dermatitis. Expert Rev Clin Pharmacol. 2018; 11(5): 467-474. Go to original source... Go to PubMed...